Related Experiment Video
Updated: May 1, 2026
06:09
Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine
Published on: January 12, 2024
1.1K
Pediatric-like therapy for adults with ALL
Hervé Dombret1, Thomas Cluzeau, Françoise Huguet
1Department of Hematology, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), University Paris Diderot, Institut Universitaire d'Hématologie, EA3518, Paris, France, herve.dombret@sls.aphp.fr.
Current Hematologic Malignancy Reports
|April 1, 2014
Summary
Pediatric-inspired chemotherapy protocols significantly improve outcomes for adult acute lymphoblastic leukemia (ALL) patients. This approach enhances response rates and survival, necessitating a reevaluation of risk factors and stem cell transplantation.
Area of Science:
- Hematology
- Pediatric Oncology
- Clinical Trials
Background:
- Adults with acute lymphoblastic leukemia (ALL) historically have worse outcomes than children.
- Initial studies suggested genetics and tolerance were key factors, but this was insufficient to explain outcome disparities.
Purpose of the Study:
- To evaluate the impact of pediatric-like chemotherapy protocols on adult ALL patient outcomes.
- To determine if intensified pediatric regimens improve response rates and survival in adults.
Main Methods:
- Retrospective analysis of adult ALL patients treated with pediatric-inspired protocols.
- Comparison of outcomes (response rates, survival) between adult and pediatric treatment regimens.
Main Results:
- Pediatric-inspired protocols have markedly improved outcomes for adult ALL patients aged 40-60 years.
- Estimated 5-year overall survival for adults receiving these protocols is now between 60% and 70%.
Conclusions:
- Intensified pediatric chemotherapy regimens are beneficial for adult ALL patients.
- The improved survival necessitates reassessment of risk stratification and the role of stem cell transplantation in adult ALL.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
01:29Drug Dosing: Infants and Children
1.0K
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
01:15Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
554
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554